212 related articles for article (PubMed ID: 33379166)
1. Prognostic Value of Baseline Radiomic Features of
Lue KH; Wu YF; Lin HH; Hsieh TC; Liu SH; Chan SC; Chen YH
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33379166
[TBL] [Abstract][Full Text] [Related]
2. Intratumor Heterogeneity Assessed by
Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Pretreatment Radiomic Features of 18F-FDG PET in Patients With Hodgkin Lymphoma.
Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
Clin Nucl Med; 2019 Oct; 44(10):e559-e565. PubMed ID: 31306204
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Overall Survival and Progression-Free Survival by the
Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
[No Abstract] [Full Text] [Related]
5. [
Travaini LL; Botta F; Derenzini E; Lo Presti G; Ferrari ME; Airò Farulla LS; Radice T; Mazzara S; Tarella C; Pileri S; Raimondi S; Ceci F
Hematol Oncol; 2023 Oct; 41(4):674-682. PubMed ID: 37209024
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an
Wang H; Zhao S; Li L; Tian R
Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
[TBL] [Abstract][Full Text] [Related]
7. Radiomics signature from [
Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Radiomic Features of
Zhou Y; Li J; Zhang X; Jia T; Zhang B; Dai N; Sang S; Deng S
Front Oncol; 2022; 12():834288. PubMed ID: 35198451
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
10. Radiomic Features of
Zhou Y; Zhu Y; Chen Z; Li J; Sang S; Deng S
Contrast Media Mol Imaging; 2021; 2021():6347404. PubMed ID: 34887712
[TBL] [Abstract][Full Text] [Related]
11. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
[TBL] [Abstract][Full Text] [Related]
12. Radiomics Features of
Kang J; Lee JH; Lee HS; Cho ES; Park EJ; Baik SH; Lee KY; Park C; Yeu Y; Clemenceau JR; Park S; Xu H; Hong C; Hwang TH
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494345
[TBL] [Abstract][Full Text] [Related]
13. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment
Choi JH; Choi JY; Woo SK; Moon JE; Lim CH; Park SB; Seo S; Ahn YC; Ahn MJ; Moon SH; Park JM
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248772
[TBL] [Abstract][Full Text] [Related]
15. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a prognostic model incorporating [
Cheng NM; Hsieh CE; Fang YD; Liao CT; Ng SH; Wang HM; Chou WC; Lin CY; Yen TC
EJNMMI Res; 2020 Jul; 10(1):74. PubMed ID: 32632638
[TBL] [Abstract][Full Text] [Related]
17. Baseline
Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y
EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763
[TBL] [Abstract][Full Text] [Related]
18. Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma.
Jiang C; Li A; Teng Y; Huang X; Ding C; Chen J; Xu J; Zhou Z
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2902-2916. PubMed ID: 35146578
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
20.
Cottereau AS; Nioche C; Dirand AS; Clerc J; Morschhauser F; Casasnovas O; Meignan M; Buvat I
J Nucl Med; 2020 Jan; 61(1):40-45. PubMed ID: 31201248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]